U.S. COMPANY FILING
Medtronic plc — Form 10-K filed 2026-06-18
Filing text preview
Medtronic's FY2026 10-K shows GAAP net income of $4.801B and non-GAAP net income of $7.120B. The company is progressing the separation of its Diabetes Business, with MiniMed's IPO completed, and made acquisitions including CathWorks and Scientia Vascular. Risks include tariffs, geopolitical conflicts, and regulatory changes.
This preview uses text already stored in ReportGem and does not fetch the document from object storage during SEO generation. Review the internal filing record and the official SEC source before relying on it.
Open filing record